You are here:

indacaterol maleate, glycopyrronium bromide (Ultibro Breezhaler)

Advice

following an abbreviated submission:

indacaterol maleate plus glycopyrronium bromide inhalation powder hard capsules (Ultibro® Breezhaler®) is accepted for use within NHS Scotland.

Indication under review: maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

For patients in whom the combination of indacaterol maleate and glycopyrronium bromide is an appropriate choice of therapy, Ultibro® Breezhaler® provides the two ingredients in a single hard capsule at a lower cost than the individual components.
 

Drug Details

Drug Name: indacaterol maleate, glycopyrronium bromide (Ultibro Breezhaler)
SMC Drug ID: 922/13
Manufacturer: Novartis Pharmaceuticals UK Ltd
Indication: maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
BNF Category:
Sub Category: 3.1 Bronchodilators
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 8 December 2014

Back